1-3 of 3
Julia A. Beaver
Close
Sort by
Journal Articles

Response Prediction to Isocitrate Dehydrogenase (IDH) Inhibitors in Patients with IDH1 - or IDH2 -Mutated Acute Myeloid Leukemia Using Clinical and Genomic Data

Emma C. Scott, Kamil Kural, Sean Smith, Michael Colgan, Alexander J. Ambinder, Gabriel Ghiaur, Nora Holmes, Dickran Kazandjian, Catherine Lai, Colleen McGuire, Lorraine Pelosof, Svetlana Petrovskaya, V. Ashutosh Rao, Amy Rosenberg, Luis Santana-Quintero, Joseph Wynne, Wenming Xiao, Yong Zhang, R. Angelo de Claro, Richard Pazdur, Julia A. Beaver, Kelly J. Norsworthy
Journal: Blood
Blood (2021) 138 (Supplement 1): 1285.
https://doi.org/10.1182/blood-2021-147099
Published: 2021
Journal Articles

Developing a Genomics Model to Predict Failure of Isocitrate Dehydrogenase (IDH) Inhibitors for Treatment of Patients with IDH1- or IDH2-Mutated Acute Myeloid Leukemia

Tigran Ghazanchyan, MS, Dickran Kazandjian, MD, Donna Przepiorka, MD PhD, Kelly J. Norsworthy, MD, Emma Scott, PhD, Luis Santana-Quintero, PhD, Svetlana Petrovskaya, PhD, Yong Zhang, PhD, Amy Rosenberg, MD, Ashutosh Rao, PhD, Richard Pazdur, MD, Ann T. Farrell, MD, Julia A. Beaver, MD, Vahan Simonyan, PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 2815.
https://doi.org/10.1182/blood-2018-99-116870
Published: 2018
Journal Articles

Enrollment of Older Adults in Clinical Trials Evaluating Patients with Hematologic Malignancies - the Food and Drug Administration (FDA) Experience

Bindu Kanapuru, MD, Harpreet Singh, MD, Adrian Myers, Julia A. Beaver, MD, Virginia Elaine Kwitkowski, MS,NP, Ann T. Farrell, MD, Richard Pazdur, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 861.
https://doi.org/10.1182/blood.V130.Suppl_1.861.861
Published: 2017